127 related articles for article (PubMed ID: 8875485)
21. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
[TBL] [Abstract][Full Text] [Related]
22. Use of a collagen-hydroxyapatite matrix in spinal fusion. A rabbit model.
Tay BK; Le AX; Heilman M; Lotz J; Bradford DS
Spine (Phila Pa 1976); 1998 Nov; 23(21):2276-81. PubMed ID: 9820906
[TBL] [Abstract][Full Text] [Related]
23. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion.
Sandhu HS; Kanim LE; Kabo JM; Toth JM; Zeegen EN; Liu D; Delamarter RB; Dawson EG
Spine (Phila Pa 1976); 1996 Sep; 21(18):2115-22. PubMed ID: 8893436
[TBL] [Abstract][Full Text] [Related]
24. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB
Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733
[TBL] [Abstract][Full Text] [Related]
25. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate.
Baskin DS; Ryan P; Sonntag V; Westmark R; Widmayer MA
Spine (Phila Pa 1976); 2003 Jun; 28(12):1219-24; discussion 1225. PubMed ID: 12811263
[TBL] [Abstract][Full Text] [Related]
26. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
[TBL] [Abstract][Full Text] [Related]
27. Spinal fusion with recombinant human growth and differentiation factor-5 combined with a mineralized collagen matrix.
Spiro RC; Thompson AY; Poser JW
Anat Rec; 2001 Aug; 263(4):388-95. PubMed ID: 11500816
[TBL] [Abstract][Full Text] [Related]
28. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
Kai T; Shao-qing G; Geng-ting D
Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
[TBL] [Abstract][Full Text] [Related]
29. Fusion performance of low-dose recombinant human bone morphogenetic protein 2 and bone marrow-derived multipotent stromal cells in biodegradable scaffolds: a comparative study in a large animal model of anterior lumbar interbody fusion.
Abbah SA; Lam CX; Ramruttun AK; Goh JC; Wong HK
Spine (Phila Pa 1976); 2011 Oct; 36(21):1752-9. PubMed ID: 21673630
[TBL] [Abstract][Full Text] [Related]
30. Lumbar interbody fusion after treatment with recombinant human bone morphogenetic protein-2 added to poly(L-lactide-co-D,L-lactide) bioresorbable implants.
Lanman TH; Hopkins TJ
Neurosurg Focus; 2004 Mar; 16(3):E9. PubMed ID: 15198497
[TBL] [Abstract][Full Text] [Related]
31. Plaster of Paris as an osteoconductive material for interbody vertebral fusion in mature sheep.
Hadjipavlou AG; Simmons JW; Yang J; Nicodemus CL; Esch O; Simmons DJ
Spine (Phila Pa 1976); 2000 Jan; 25(1):10-5; discussion 16. PubMed ID: 10647154
[TBL] [Abstract][Full Text] [Related]
32. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements.
Sandhu HS; Kanim LE; Toth JM; Kabo JM; Liu D; Delamarter RB; Dawson EG
Spine (Phila Pa 1976); 1997 Jun; 22(11):1171-80. PubMed ID: 9201852
[TBL] [Abstract][Full Text] [Related]
33. Lumbar intertransverse-process spinal arthrodesis with use of a bovine bone-derived osteoinductive protein. A preliminary report.
Boden SD; Schimandle JH; Hutton WC
J Bone Joint Surg Am; 1995 Sep; 77(9):1404-17. PubMed ID: 7673292
[TBL] [Abstract][Full Text] [Related]
34. The influence of orthotopic paraspinal muscle-pediculated bone flaps on posterior spinal fusion in a canine model.
Xi C; Li Y; Chi Z; Pei L; Ji Y; Wang X; Yan J
Spine (Phila Pa 1976); 2011 Jan; 36(1):E20-6. PubMed ID: 20975622
[TBL] [Abstract][Full Text] [Related]
35. How does recombinant human bone morphogenetic protein-4 enhance posterior spinal fusion?
Cheng JC; Guo X; Law LP; Lee KM; Chow DH; Rosier R
Spine (Phila Pa 1976); 2002 Mar; 27(5):467-74. PubMed ID: 11880831
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a new formulation of demineralized bone matrix putty in a rabbit posterolateral spinal fusion model.
Kiely PD; Brecevich AT; Taher F; Nguyen JT; Cammisa FP; Abjornson C
Spine J; 2014 Sep; 14(9):2155-63. PubMed ID: 24512696
[TBL] [Abstract][Full Text] [Related]
37. Effect of nano-hydroxyapatite/collagen composite and bone morphogenetic protein-2 on lumbar intertransverse fusion in rabbits.
Sun TS; Guan K; Shi SS; Zhu B; Zheng YJ; Cui FZ; Zhang W; Liao SS
Chin J Traumatol; 2004 Feb; 7(1):18-24. PubMed ID: 14728813
[TBL] [Abstract][Full Text] [Related]
38. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion.
Helm GA; Sheehan JM; Sheehan JP; Jane JA; diPierro CG; Simmons NE; Gillies GT; Kallmes DF; Sweeney TM
J Neurosurg; 1997 Jan; 86(1):93-100. PubMed ID: 8988086
[TBL] [Abstract][Full Text] [Related]
39. The osteoinductive properties of Nell-1 in a rat spinal fusion model.
Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC
Spine J; 2007; 7(1):50-60. PubMed ID: 17197333
[TBL] [Abstract][Full Text] [Related]
40. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
